News
Former Bristol-Myers Squibb Head of Pharmacometrics Dr. Amit Roy Joins PumasAI to Support Drug Development Programs and DeepPumas Application
July 24, 2023 | Press ReleasePumasAI, a science-first organization that turns data into life-saving decisions faster, announced today that Dr. Amit Roy, former Executive Director and Head of Pharmacometrics at Bristol-Myers Squibb (BMS), has joined PumasAI as Distinguished Scientist. In his new role, Dr. Roy will contribute to PumasAI’s growth trajectory by providing model-informed drug development (MIDD) expertise to accelerate drug development programs...
Pumas-AI Continues to Expand Pharmaceutical Pharmacokinetics and Clinical Pharmacology Expertise with New Head of Business Development
March 15, 2023 | Press ReleasePumas-AI, a science-first organization that turns data into life-saving decisions faster, announced today that Dhanashri Gudi, Ph.D. has joined the company’s senior leadership team as Head of Business Development to continue to drive the year-over-year double-digit growth that Pumas-AI has experienced since inception. Dr. Gudi has spent nearly 20 years in the pharmaceutical industry, focused on drug metabolism...
How Machine Learning Will Change the Future of Pharmaceuticals: Q&A with CEO Joga Gobburu
February 02, 2023 | BlogThe machine learning market is estimated to be worth a staggering $106.52 billion by the year 2030, according to Market Research Future. Combine this with the rise of consumer interest in artificial intelligence (AI) tools like ChatGPT, the world is beginning to mainstream these technologies. As this occurs, scientists are developing tools to level-up drug development analytics to create stronger outcomes and potentially save more lives...
Pumas-AI Hires Dr. Salim Bouchene and Expands Consulting Practice in Europe
December 06, 2022 | Press ReleaseThis new hire highlights expansions that Pumas-AI has made across the globe in recent years. As a senior scientist, Dr. Bouchene will focus on modeling and simulation and their application to pharmaceutical drug development. He will support Pumas-AI’s global client base through pharmacometrics and clinical pharmacology consulting, PK/PD modeling of clinical and preclinical data across various therapeutic areas...
International Society of Pharmacometrics Names Pumas-AI Co-Founder Dr. Vijay Ivaturi as President-Elect
December 01, 2022 | Press ReleaseCo-Founder and Chief Scientific Officer (CSO) Vijay Ivaturi, PhD, has been elected as the next President of the International Society of Pharmacometrics (ISoP). Dr. Ivaturi will serve a one-year term as President-Elect effective immediately and will assume the ISoP presidency in January 2024, for a two-year term. As President-Elect, Dr. Ivaturi will oversee the development of ISoP’s three-year strategic plan...
New Clinical Pharmacology Desktop Software Launched by Pumas-AI is Easier to Use and Compliant with Global Regulations
September 30, 2022 | Press ReleasePumas-AI, a science-first organization that turns data into life-saving decisions faster, announced today that it has launched Pumas-CP - a new clinical pharmacology platform for non-compartmental analysis (NCA), bioequivalence analysis, and pharmacokinetic and pharmacodynamic (PK/PD) modeling. “Pharmacokineticists and clinical pharmacologists are looking for a simple tool to manage...
Former BMS Quality Director Joins Pumas-AI Scientists as Head of Quality Assurance and Compliance Amid 3X Growth Period
August 04, 2022 | Press ReleasePumas-AI, a science-first organization that turns data into life-saving decisions faster, announced today that Peter J. Miller has joined the organization as Head of Quality Assurance and Compliance. In his role, Mr. Miller will further strengthen and build upon the quality of deliverables and products that Pumas-AI scientists produce, including clinical pharmacology, pharmacometrics...
Powerful Pumas Software is Now Available for Desktop Download
August 02, 2022 | Press ReleasePumas-AI, a science-first organization that turns data into life-saving decisions faster, announced today that its Pumas software is now available for desktop download. Pumas is a one-stop integrated modeling and simulation platform designed to multiply productivity across the drug development lifecycle, turning data into life-saving decisions faster.
Model-Informed Drug Development: Everything You Need to Know
July 28, 2022 | BlogAccording to the U.S. Food & Drug Administration (FDA), “model-informed drug development (MIDD) is an approach that involves developing and applying exposure-based, biological and statistical models derived from preclinical and clinical data sources to inform drug development and decision-making.” In 2018, the FDA created a pilot program to explore MIDD further...
Pumas-AI looks to democratize access to drug development tools
September 07, 2021 | Press ReleaseThe University of Maryland, Baltimore startup recently completed a big upgrade for its 2.0 version. Here's why the cofounders say it matters for science, and healthcare. For the cofounders of University of Maryland, Baltimore startup Pumas-AI, technology has the power to democratize access to advanced tools. The startup’s pharmaceutical modeling and simulation platform has two products...
UMB Startup Pumas-AI Receives Exclusive License
August 18, 2021 | Press ReleasePumas-AI, a University of Maryland, Baltimore (UMB) startup company, has been granted worldwide, exclusive rights to enhancements to Pumas, an end-to-end pharmaceutical modeling and simulation platform for quantitative analysis across the drug development lifecycle. Pumas 2.0 builds on the company’s existing platform, which also employs technology licensed from UMB...
Collaborative work by Pumas-AI and Otsuka to be presented at NKF '21
February 18, 2021 | BlogWe are excited to announce that the collaborative work performed by Otsuka Pharmaceutical Development & Commercialization and Pumas-AI scientists will be presented at National Kidney Foundation 2021 on April 6-10, 2021! The modeling used Pumas software to explore urine osmolality and GFR relationship. Urine Osmolality (Uosm) Is a Reasonable Marker of Acute (TKV) and Longer-term...
Congrats to Dr. Rackauckas – awarded 2020 ISoP Emerging Scientist!
November 09, 2020 | BlogDr. Christopher Rackauckas, our Director of Scientific Research, was recently awarded for the 2020 ISoP Emerging Scientist Award. The International Society of Pharmacometrics (ISoP) Awards Ceremony was hosted by the Eleventh American Conference of Pharmacometrics (ACoP11) on Monday, November 9, 2020. The Emerging Scientist Award, the highest early career award given by ISoP, was granted to...
UMB-born startup launches pharmaceutical modeling platform Pumas 1.0
August 12, 2020 | Press ReleaseA startup launched out by faculty at University of Maryland, Baltimore and MIT researchers collaborated to launch Pumas 1.0, a predictive analytics platform that aids in the development cycle of pharmaceutical drugs. What that means is Pumas 1.0 takes the data a drug company has and simulates the success rate or possible outcome of a drug. Creating models and simulations through the algorithm...
UMB Grants Pumas-AI Exclusive License for Lyv, a Cutting-Edge Clinical Decision Support System
May 07, 2020 | Press ReleasePumas-AI, a University of Maryland, Baltimore (UMB) startup company, has been granted worldwide, exclusive rights to Lyv, a cutting-edge clinical decision support system designed to help health care professionals personalize treatment trajectories for patients in real-time. The Lyv platform leverages clinical research and Electronic Health Record (EHR) data from millions of patients to derive…
University of Maryland, Baltimore Researchers' Startup, Pumas-AI, Launches Cutting-Edge Healthcare Software
August 08, 2019 | FeaturePumas-AI, a new University of Maryland, Baltimore (UMB) startup company established by University of Maryland School of Pharmacy (SOP) faculty members Vijay Ivaturi, PhD, assistant professor, and Joga Gobburu, PhD, MBA, professor, has released its first, cutting-edge software platform for pharmaceutical researchers and clinicians. Known as Pharmaceutical Modeling and Simulation (Pumas), the s...
Pumas-AI Launches Julia Language-Based Software to Advance Drug Development, Patient Care
August 04, 2019 | FeaturePumas-AI – a new company established by University of Maryland School of Pharmacy faculty members Vijay Ivaturi, PhD, assistant professor in the Department of Pharmacy Practice and Science (PPS), and Joga Gobburu, PhD, MBA, professor in PPS – is proud to announce the release of its first cutting-edge software platform for pharmaceutical researchers and clinicians. Known as Pharmaceutical...
Researchers establish Pumas-AI, launch Pumas pharmaceutical software
July 22, 2019 | FEATUREPumas-AI, a new company established by University of Maryland School of Pharmacy faculty members Vijay Ivaturi, PhD, assistant professor in the Department of Pharmacy Practice and Science, and Joga Gobburu, PhD, MBA, professor in the department, is proud to announce the release of its first, cutting-edge software platform for pharmaceutical researchers and clinicians. Known as Pharmaceutical...
The Future of Modelling and Simulations in Pharmacometrics with Julia
July 19, 2019 | blogPharmacometricians have been early adopters of mathematical programming tools. We use tools that allow us to solve real problems. However, given the diversity of problems that we solve, our field has seen a split in the languages that we use due to the problems they are tailored to solve. R has become a staple in the community due to its strong statistics, data manipulation and plotting libra...
The story of Pumas
July 19, 2019 | blogAt the outset, I would like to acknowledge and thank all those who contributed to development of Pumas. Here is a complete list in no particular order: Chris Rackauckas; Simon Byrne; Andreas Noack; Patrick Mogensen; José Bayoán Santiago Calderón; Yingbo Ma; Vaibhav Dixit; Xingjian Guo; Shubham Maddhashiya; Harrison Gordin; David Widmann; Joakim Nyberg; Joga Gobburu. I would also like to ac...
